Literature DB >> 15571322

Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Annette Lebeau1, Claudia Müller-Aufdemkamp, Clarissa Allmacher, Ulrich Sauer, Andreas Nerlich, Ralf Lichtinghagen, Udo Löhrs.   

Abstract

The expression of matrix metalloproteinases (MMPs) with type IV collagenase activity has been associated with tumour invasion and metastatic potential in experimental models. We studied whether the cellular localization of MMP expression provides useful information on tumour behaviour in human breast cancer. Immunohistochemistry and non-radioisotopic-detected in situ hybridization were used to study protein and mRNA expression profiles for MMPs-2, -3 and -9 in paraffin sections of 70 invasive breast carcinomas. Protein and mRNA expression of the MMPs was observed in tumour as well as in peritumoural stromal cells. MMP protein expression was increased at the invasive border (p < 0.05). Grade 3 carcinomas expressed MMP-2 mRNA in significantly more tumour cells than grade 2 carcinomas (p = 0.006). Ductal carcinomas with an extensive intraductal component were characterized by the lowest percentages of MMPs-2 and -3 mRNA expressing peritumoural stromal cells (p < 0.05). No correlation was observed between MMP protein/mRNA expression and pTNM classification. In conclusion our results indicate that the expression of MMPs is associated with tumour behaviour. The correlation of MMPs-2 and -3 expression in peritumoural stromal cells with tumour type, shown for the first time, suggests that transcriptional regulation of these MMPs in stromal cells is important for the growth pattern of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571322     DOI: 10.1023/b:hijo.0000045943.26251.24

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  51 in total

1.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.

Authors:  M P Shekhar; J Werdell; S J Santner; R J Pauley; L Tait
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

2.  Overview of matrix metalloproteinase expression in cultured human cells.

Authors:  T A Giambernardi; G M Grant; G P Taylor; R J Hay; V M Maher; J J McCormick; R J Klebe
Journal:  Matrix Biol       Date:  1998-03       Impact factor: 11.583

3.  Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy.

Authors:  A Talvensaari-Mattila; P Pääkko; G Blanco-Sequeiros; T Turpeenniemi-Hujanen
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

4.  Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.

Authors:  L Nakopoulou; I Giannopoulou; H Gakiopoulou; H Liapis; A Tzonou; P S Davaris
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

5.  MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.

Authors:  Christian F Singer; Nicole Kronsteiner; Erika Marton; Marion Kubista; Kevin J Cullen; Kora Hirtenlehner; Michael Seifert; Ernst Kubista
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

6.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

7.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Authors:  H Ueno; H Nakamura; M Inoue; K Imai; M Noguchi; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

8.  Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy.

Authors:  M Polette; N Gilbert; I Stas; B Nawrocki; A Nöel; A Remacle; W G Stetler-Stevenson; P Birembaut; M Foidart
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

10.  Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

Authors:  A G Remacle; A Noël; C Duggan; E McDermott; N O'Higgins; J M Foidart; M J Duffy
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more
  8 in total

1.  Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.

Authors:  Melanie Ruszczyk; Gary Zirpoli; Shicha Kumar; Elisa V Bandera; Dana H Bovbjerg; Lina Jandorf; Thaer Khoury; Helena Hwang; Gregory Ciupak; Karen Pawlish; Pepper Schedin; Patricia Masso-Welch; Christine B Ambrosone; Chi-Chen Hong
Journal:  Cancer Causes Control       Date:  2015-11-30       Impact factor: 2.506

2.  Plasma matrix metalloproteinase 2 levels and breast cancer risk.

Authors:  Sarah A Aroner; Bernard A Rosner; Rulla M Tamimi; Shelley S Tworoger; Nadja Baur; Thomas O Joos; Susan E Hankinson
Journal:  Cancer Epidemiol       Date:  2015-03-19       Impact factor: 2.984

3.  Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Ji-Rong Long; Xiao-ou Shu; Ying Zheng; Qiuyin Cai; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

4.  Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.

Authors:  Amani Ahmed Alrehaili; Amal Fathi Gharib; Rehab Ahmed Karam; Reem Ali Alhakami; Wael Hassan El Sawy; Tamer Mohamed Abd Elrahman
Journal:  Mol Biol Rep       Date:  2019-12-09       Impact factor: 2.316

5.  Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas.

Authors:  Otto Luiz Dutra Cerqueira; Mayara Carolline Silva Botelho; Ana Paula Zen Petisco Fiore; Cynthia Aparecida Bueno de Toledo Osório; Rebeka Tomasin; Mauro César Cafundó Morais; Rossana Verónica Mendoza López; Elaine Cristina Cardoso; Santiago Andres Vilella-Arias; Eduardo Moraes Reis; Alexandre Bruni-Cardoso
Journal:  Neoplasia       Date:  2022-05-05       Impact factor: 6.218

6.  Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Authors:  Rita C S Figueira; Luciana R Gomes; João S Neto; Fabricio C Silva; Ismael D C G Silva; Mari C Sogayar
Journal:  BMC Cancer       Date:  2009-01-14       Impact factor: 4.430

7.  Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma.

Authors:  B O Li; Chao Meng; Xufeng Zhang; Damin Cong; Xin Gao; Wanlong Gao; Donghui Ju; Shaoshan Hu
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

8.  The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.

Authors:  Hai Li; Zhenwei Qiu; Feng Li; Chunlei Wang
Journal:  Oncol Lett       Date:  2017-09-13       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.